ProMeris Duo

RSS
Withdrawn

This medicine's authorisation has been withdrawn

metaflumizone / amitraz
MedicineVeterinaryWithdrawn
  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for ProMeris Duo has been withdrawn at the request of the marketing authorisation holder.

български (BG) (268.89 KB - PDF)

View

español (ES) (234.19 KB - PDF)

View

čeština (CS) (263.37 KB - PDF)

View

dansk (DA) (231.6 KB - PDF)

View

Deutsch (DE) (237.07 KB - PDF)

View

eesti keel (ET) (231.04 KB - PDF)

View

ελληνικά (EL) (273.19 KB - PDF)

View

français (FR) (234.85 KB - PDF)

View

italiano (IT) (230.99 KB - PDF)

View

latviešu valoda (LV) (271.61 KB - PDF)

View

lietuvių kalba (LT) (260.01 KB - PDF)

View

magyar (HU) (258.27 KB - PDF)

View

Malti (MT) (269.89 KB - PDF)

View

Nederlands (NL) (232.34 KB - PDF)

View

polski (PL) (261.12 KB - PDF)

View

português (PT) (233.54 KB - PDF)

View

română (RO) (259.96 KB - PDF)

View

slovenčina (SK) (264.08 KB - PDF)

View

slovenščina (SL) (250.13 KB - PDF)

View

Suomi (FI) (232.08 KB - PDF)

View

svenska (SV) (233.25 KB - PDF)

View

Product information

български (BG) (555.84 KB - PDF)

View

español (ES) (463.63 KB - PDF)

View

čeština (CS) (510.99 KB - PDF)

View

dansk (DA) (459.91 KB - PDF)

View

Deutsch (DE) (565.04 KB - PDF)

View

eesti keel (ET) (467.29 KB - PDF)

View

ελληνικά (EL) (564.31 KB - PDF)

View

français (FR) (554.89 KB - PDF)

View

íslenska (IS) (462.33 KB - PDF)

View

italiano (IT) (606.2 KB - PDF)

View

latviešu valoda (LV) (595.88 KB - PDF)

View

lietuvių kalba (LT) (529.65 KB - PDF)

View

magyar (HU) (592.54 KB - PDF)

View

Malti (MT) (547.9 KB - PDF)

View

Nederlands (NL) (466.67 KB - PDF)

View

norsk (NO) (546.57 KB - PDF)

View

polski (PL) (634.45 KB - PDF)

View

português (PT) (565.16 KB - PDF)

View

română (RO) (532.02 KB - PDF)

View

slovenčina (SK) (543.1 KB - PDF)

View

slovenščina (SL) (539.48 KB - PDF)

View

Suomi (FI) (477.98 KB - PDF)

View

svenska (SV) (457.92 KB - PDF)

View
Latest procedure affecting product information: IB/0011
08/07/2015

български (BG) (197.83 KB - PDF)

View

español (ES) (145.18 KB - PDF)

View

čeština (CS) (186.36 KB - PDF)

View

dansk (DA) (145.68 KB - PDF)

View

Deutsch (DE) (154.34 KB - PDF)

View

eesti keel (ET) (145.19 KB - PDF)

View

ελληνικά (EL) (198.38 KB - PDF)

View

français (FR) (145.66 KB - PDF)

View

íslenska (IS) (146.14 KB - PDF)

View

italiano (IT) (145.84 KB - PDF)

View

latviešu valoda (LV) (199.11 KB - PDF)

View

lietuvių kalba (LT) (184.36 KB - PDF)

View

magyar (HU) (185.85 KB - PDF)

View

Nederlands (NL) (145.6 KB - PDF)

View

norsk (NO) (145.55 KB - PDF)

View

polski (PL) (164.96 KB - PDF)

View

português (PT) (145.14 KB - PDF)

View

română (RO) (146.57 KB - PDF)

View

slovenčina (SK) (183.09 KB - PDF)

View

slovenščina (SL) (162.45 KB - PDF)

View

Suomi (FI) (149.94 KB - PDF)

View

svenska (SV) (145.54 KB - PDF)

View

Product details

Name of medicine
ProMeris Duo
Active substance
  • metaflumizone
  • amitraz
International non-proprietary name (INN) or common name
  • metaflumizone
  • amitraz
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QP53AD51

Pharmacotherapeutic group

Ectoparasiticides for topical use, incl. insecticides

Therapeutic indication

For the treatment and prevention of infestations by fleas (Ctenocephalides canis and C. felis), and ticks (Ixodes ricinus, Ixodes hexagonus, Rhipicephalus sanguineus, Dermacentor reticulatus and Dermacentor variabilis), and treatment of demodicosis (caused by Demodex spp.) and lice (Trichodectes canis) in dogs.

The veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).

Authorisation details

EMA product number
EMEA/V/C/000108
Marketing authorisation holder
Pfizer Limited 

Pfizer Limited
Ramsgate Road
Sandwich
Kent CT13 9NJ
United Kingdom

Marketing authorisation issued
19/12/2006
Revision
7

Assessment history

This page was last updated on

Share this page